Animec 18.7mg/g Oral Paste for Horses
Chanelle Vet UK Ltd
Address: Chanelle Group
1st Floor, Freemans House
127 High Street, Hungerford
Berkshire, RG17 ODL
Telephone: 01908 843636
Fax: 01908 847401
Company name: Chanelle Animal Health Limited
7 Rodney Street
Tel & Fax: 01568 750432
A white paste containing 18.7mg/g ivermectin.
Treatment of nematode or arthropod infections due to:
Strongylus vulgaris (adults and L4 stage larvae [arterial]), Strongylus edentatus (adults and L4 stage larvae [tissue]), Strongylus equinus (adults)
Small strongyles- adults and luminal L4 stage larvae (including benzimidazole resistant strains)
Cyathostomum spp, Cylicocyclus spp., Cylicodontophorus spp., Cylicostephanus spp., Gyalocephalus spp.
Parascaris equorum (luminal L5 larvae and adults)
Oxyuris equi (L4 stage larvae and adults)
Onchocerca spp (microfilariae)
Gasterophilus spp (oral and gastric stages)
One syringe division of paste per 100 kg body weight (based on a recommended dosage of 200 microgram ivermectin per kg body weight). The syringe containing 6.42 g of paste delivers sufficient paste to treat 600 kg of bodyweight at the recommended dose rate. The syringe containing 7.49 g of paste delivers sufficient paste to treat 700 kg of bodyweight at the recommended dose rate.
The paste is given by oral route.
Advice on correct administration
The weight of the horse should be accurately determined for the correct use of the paste. The animal’s mouth should be free from food to ensure swallowing. Turn the screw gauge on the syringe plunger to the body weight of the horse.
The tip of the syringe barrel should be inserted at the interdental space (the gap between the front and back teeth) and the paste deposited on the base of the tongue. Advance the plunger as far as it will go, depositing the medication on the base of the tongue. Immediately elevate the horse’s head for a few seconds to ensure swallowing.
Do not use in horses with known hypersensitivity to the active substance.
Do not use in dogs or cats as severe adverse reactions may occur.
Meat and offal: 34 days. Do not use in mares producing milk for human consumption.
Special precautions for use in animals
Some horses with heavy infections of Onchocerca spp. microfilariae have experienced oedema and pruritus following treatment, such reactions are assumed to be the result of death of large numbers of microfilariae. These signs resolve within a few days but symptomatic treatment may be advisable.
Care should be taken to avoid the following practices because they increase the risk of development of resistance and could ultimately result in ineffective therapy:
· Too frequent and repeated use of anthelmintics from the same class over an extended period of time
· Underdosing, which may be due to underestimation of body weight or misadministration of the product.
Suspected clinical cases of resistance to anthelmintics should be further investigated using appropriate tests (e.g. Faecal Egg Count Reduction Test). Where the results of the test(s) strongly suggest resistance to a particular anthelmintic, an anthelmintic belonging to another pharmacological class and having a different mode of action should be used. Veterinary advice should be given on appropriate dosing programs and stock management to achieve adequate parasite control and reduce the likelihood of anthelmintic resistance developing. In the event that a product is suspected of being ineffective, the animal owner is advised to seek veterinary advice. Resistance to ivermectin has been reported in Parascaris equorum. Therefore, the use of this product should be based on local farm epidemiological information about susceptibility of nematodes and recommendations on how to limit further selection for resistance to anthelmintics.
The product has been formulated for use in horses only. Cats, dogs, especially Collies, Old English Sheepdogs and related breeds or crosses, and also in turtles and tortoises may be adversely affected by the concentration of Ivermectin in this product if they are allowed to ingest spilled paste or have access to used syringes.
The product can be administered to mares at any stages of pregnancy or lactation.
Mild transitory signs (slowed pupillary light response and depression) have been seen at a higher dose of 1.8 mg/kg (9 times the recommended dose level). Other signs seen at higher doses include mydriasis (dilation of the pupil), ataxia (incoordination), tremors (shaking), stupor (dull), coma and death. The less severe signs have been transitory.
Although no antidote has been identified, symptomatic therapy may be beneficial.
Special precautions to be taken by the person administering the veterinary medicinal product to animals
Do not smoke, eat or drink while handling the product.
Wash hands after use.
This product may cause skin and eye irritation. Therefore, the user should avoid contact of the product with the skin and the eyes. In case of contact, rinse immediately with plenty of water.
In the case of accidental ingestion or eye irritation after contact seek medical advice immediately and show the package insert or the label to the physician.
Do not store above 25°C.
EXTREMELY DANGEROUS TO FISH AND AQUATIC LIFE. Do not contaminate surface waters or ditches with product or used container. Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements.
Syringe containing 6.42g or 7.49 g paste
ECO Animal Health Ltd., 78 Coombe Road, New Malden, Surrey, KT3 4QS, United Kingdom